Company Overview of Rempex Pharmaceuticals, Inc.
As of December 3, 2013 Rempex Pharmaceuticals, Inc. has been acquired by The Medicines Company. Rempex Pharmaceuticals, Inc. discovers and develops antibacterial drugs. The company offers Minocin IV, a Minocycline for injection to wholesale pharmaceutical distributors in the United States. It is also developing RPX-602, a reformulation of Minocin IV; and Carbavance, an investigational agent that is a combination of a beta-lactamase inhibitor with a carbapenem. The company was founded in 2011 and is based in San Diego, California.
11535 Sorrento Valley Road
San Diego, CA 92121
Founded in 2011
Key Executives for Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. does not have any Key Executives recorded.
Rempex Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Rempex Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.